Roche Diabetes Care Inc.
Indianapolis, IN Part of Foundation Medicine, Inc.
- UEI
- F6JDDN8L9JM4
- CAGE
- 7DZ31
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Boston, MA
EHXPZ92G4AD1
-
Parent
Boston, MA
EHXPZ92G4AD1
- SAM.gov registration date
- Physical address
- 9115 Hague Rd, Indianapolis, IN 46256, USA
- Website
- accu-chek.com
- Founded
- 1974
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 59 Miscellaneous Retail
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $392,000 |
| FY2025 | $718,148 |
| FY2024 | $264,093 |
| FY2023 | $1,607,664 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $392,000 |
Contract vehicles
No active vehicles.
1 expired vehicle
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Nova Biomedical Corp | Waltham, MA | 334516 Analytical Laboratory Instrument Manufacturing |
| Kyowa Medical Corporation | Yokohama, Kanagawa | 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers |
| Abbott Diabetes Care Sales Corp | Alameda, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Tosoh USA | Grove City, OH | 334516 Analytical Laboratory Instrument Manufacturing |
| Mckesson Drug Company | — | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Roche Diabetes Care Inc., a for-profit manufacturer of diabetes management products and in-vitro diagnostic reagents headquartered in Indianapolis, Indiana, operates as a prime contractor delivering blood glucose monitors, test strips, lancets, control solutions, and diagnostic testing supplies to federal healthcare organizations under GSA Federal Supply Schedule contract FSS-65-VII and related blanket purchase agreements. The company is a subsidiary of Foundation Medicine, Inc. (foreign-owned parent) and competes exclusively in full-and-open procurements, holding no set-aside designations.
Roche's federal footprint concentrates overwhelmingly on Indian Health Service diabetes care procurement. The Indian Health Service accounts for 62 of 121 prime awards (51% of recent award count) with $13.4 million combined potential value across delivery orders and BPA calls supporting diabetes supply programs at facilities including the Phoenix Indian Medical Center and Gallup Indian Medical Center. The Department of Veterans Affairs Veterans Integrated Service Network 12 anchors $1.99 billion in potential value — nearly all Roche's federal exposure by dollar magnitude — from a single GSA Federal Supply Schedule contract awarded April 1, 2026 with ceiling through March 31, 2031. The Department of Justice Bureau of Prisons Federal Medical Center Rochester has placed 36 awards ($955 thousand combined potential value) for laboratory reagents and diagnostic test materials delivered to Roche's Castleton, Indiana facility. The Department of Veterans Affairs Veterans Integrated Service Network 15 and Network 22 account for the remaining activity.
Representative work includes a $250 thousand BPA call from IHS dated September 27, 2026 for diabetes care supplies at the Phoenix Indian Medical Center under FSS-65-VII, a $550 thousand delivery order (Modification 2) to IHS in March 2025 for diabetes supplies to Gallup Indian Medical Center with completion through March 31, 2030, and recurring sub-$50 thousand delivery orders to the Bureau of Prisons Federal Medical Center Rochester for reagents and lab supplies placed monthly or quarterly from 2021 through 2023.
Roche's vehicle position centers on the GSA Federal Supply Schedule contract FSS-65-VII (In-Vitro Diagnostics, Reagents, Test Kits & Test Sets), which carries 79 task orders and $14 million in combined potential value. The company also operates two active single-award blanket purchase agreements with IHS: a $2 million BPA established September 23, 2021 (extending through September 26, 2026) and a $1.660 million BPA awarded May 25, 2023 (through May 14, 2026). Activity has declined sharply — 25 awards in 2023, then 2 awards in both 2024 and 2025, with 2 awards in 2026 — reflecting the shift from high-volume IHS and Bureau of Prisons delivery orders to lower-frequency VA work. Only $250 thousand in combined potential value faces ultimate completion within the next twenty-four months, exposing minimal recompete risk in the near term. Primary NAICS framing is 325413 (In-Vitro Diagnostic Substance Manufacturing), accounting for 103 of 121 awards, with secondary exposure in medical equipment wholesale and pharmaceutical preparation manufacturing.
Quick answers
Is Roche Diabetes Care Inc. registered in SAM.gov?
Yes. Roche Diabetes Care Inc.'s SAM.gov registration is active through May 28, 2027.
Which contract vehicles does Roche Diabetes Care Inc. hold?
Roche Diabetes Care Inc. holds a place on 1 federal contract vehicle: FSS-65-VII.
How much has Roche Diabetes Care Inc. received in federal contracts?
Federal contracts obligated $718,148 to Roche Diabetes Care Inc. in fiscal year 2025 and $2,981,905 in fiscal years 2023 through 2027.
How does Roche Diabetes Care Inc. rank among federal contractors?
Roche Diabetes Care Inc. ranked #30 in NAICS 325413 in FY2025.
What is Roche Diabetes Care Inc.'s most recent federal award?
Roche Diabetes Care Inc.'s most recent federal contract award is BPA call - roche diabetes care, supplies, pimc, materials management, POP: 09/27/2026 - 09/26/2027 (75H71226F28008), from Indian Health Service, on September 27, 2026.
On GovTribe
See Roche Diabetes Care Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors